Corvus Pharmaceuticals Inc (CRVS)
1.92
+0.19
(+10.98%)
USD |
NASDAQ |
May 03, 16:00
2.05
+0.13
(+6.77%)
After-Hours: 20:00
Corvus Pharmaceuticals Shares Outstanding: 49.04M for March 19, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 19, 2024 | 49.04M |
December 31, 2023 | 49.04M |
November 07, 2023 | 49.04M |
September 30, 2023 | 49.04M |
August 08, 2023 | 48.97M |
June 30, 2023 | 48.90M |
April 18, 2023 | 46.57M |
March 31, 2023 | 46.57M |
March 28, 2023 | 46.57M |
March 27, 2023 | 46.57M |
December 31, 2022 | 46.55M |
November 03, 2022 | 46.55M |
September 30, 2022 | 46.55M |
August 08, 2022 | 46.55M |
June 30, 2022 | 46.55M |
May 05, 2022 | 46.55M |
April 18, 2022 | 46.55M |
March 31, 2022 | 46.55M |
March 10, 2022 | 46.55M |
December 31, 2021 | 46.55M |
November 01, 2021 | 46.55M |
September 30, 2021 | 46.55M |
August 02, 2021 | 42.42M |
June 30, 2021 | 42.42M |
April 29, 2021 | 38.31M |
Date | Value |
---|---|
April 19, 2021 | 38.31M |
March 31, 2021 | 38.31M |
March 25, 2021 | 38.31M |
February 17, 2021 | 37.85M |
December 31, 2020 | 28.37M |
October 29, 2020 | 28.06M |
September 30, 2020 | 28.06M |
July 30, 2020 | 28.04M |
June 30, 2020 | 28.03M |
April 30, 2020 | 27.95M |
April 13, 2020 | 27.95M |
March 31, 2020 | 27.95M |
March 09, 2020 | 29.33M |
January 31, 2020 | 27.95M |
December 31, 2019 | 27.95M |
November 08, 2019 | 27.95M |
October 29, 2019 | 29.41M |
September 30, 2019 | 29.41M |
August 01, 2019 | 29.39M |
June 30, 2019 | 29.35M |
May 09, 2019 | 29.33M |
April 24, 2019 | 29.33M |
March 31, 2019 | 29.33M |
March 07, 2019 | 29.33M |
December 31, 2018 | 29.32M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
27.95M
Minimum
Nov 08 2019
49.04M
Maximum
Sep 30 2023
39.12M
Average
42.42M
Median
Jun 30 2021
Shares Outstanding Benchmarks
Cyclacel Pharmaceuticals Inc | 1.318M |
Arbutus Biopharma Corp | 180.17M |
Oragenics Inc | 4.481M |
Relmada Therapeutics Inc | 30.17M |
MAIA Biotechnology Inc | 20.58M |